Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis
Dermatology Online Journal · 2024
DOI: 10.5070/d330464111 ↗Kurz gefasst
Fallbericht in der Zeitschrift Dermatology Online Journal, 2024. Verfasst von Kyle Mueller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA Department of Dermatology, Tulane University, New Orleans…. Hauptthemen laut MEDLINE: Crotonates, Hydroxybutyrates, Nitriles, Psoriasis.
Abstract (Originalsprache)
Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who developed inverse psoriasis after starting teriflunomide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA Department of Dermatology, Tulane University, New Orleans, Louisiana, USA. dkuraiti@tulane.edu.
Zitieren
APA
Mueller, K., Pei, S., & Kuraitis, D. (2024). Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis. Dermatology Online Journal. https://doi.org/10.5070/d330464111
Vancouver
Mueller K, Pei S, Kuraitis D. Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis. Dermatology Online Journal. 2024. doi:10.5070/d330464111
BibTeX
@article{Mueller2024,
author = {Mueller, Kyle and Pei, Susan and Kuraitis, Drew},
title = {Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis},
journal = {Dermatology Online Journal},
year = {2024},
doi = {10.5070/d330464111}
}
EUVIMED